Introduction {#s1}
============

Chemokines are small proteins that signal upon binding seven-pass-transmembrane G protein-coupled receptors (GPCRs) ([@bib64]). Chemokine receptors are classified into four categories namely, CXCR, CCR, XCR and CX3CR ([@bib42]). Chemokines were originally shown to function in the context of immune response, but were thereafter implicated in a range of developmental processes such as angiogenesis ([@bib54]), neural development ([@bib66]) and migration of non-immune cells. Following binding to their ligands, chemokine receptors activate a wide range of effectors, including adenylyl cyclases, phospholipase isoforms, protein tyrosine kinases, ion channels, and mitogen-activated protein kinases (MAPKs). These responses can result from the activation of G proteins, as well as from other second messengers to initiate G-protein-independent signaling ([@bib53]). For example, in addition to signaling through the G protein Gαi and Gβγ, chemokine receptors can initiate JAK/STAT signaling and signal through β-arrestin, in the context of chemotaxis of hematopoietic progenitor cells and in the context of activation and release of granules in neutrophils, respectively ([@bib1]; [@bib63]). Thus, chemokine receptor signaling through a range of second messenger molecules potentially expands an individual chemokine receptor's ability to control qualitatively different cellular responses.

In many cases, the same chemokine receptor is expressed in different cell types, where it initiates very different types of biological responses. For example, Cxcr4 expression in hematopoietic progenitors is important for these cells' mobilization ([@bib40]), yet, the same receptor, when expressed in neuronal progenitor cells inhibits their proliferation ([@bib28]). Similarly, CCR7 is expressed by T lymphocytes to facilitate their homing to secondary lymphoid organs ([@bib49]), but it is also expressed in and important for the development of the human placenta ([@bib11]). On the other hand, in early zebrafish embryos Ccr7 is expressed broadly and is involved in proper dorsoventral axis formation ([@bib61]). These observations raise the question of how different chemokine receptors control such a wide range of different processes.

Several models have been suggested to explain this phenomenon and these are collectively referred to as 'signaling bias' ([@bib53]). Related to that, it has been recently demonstrated that the extracellular and membrane-spanning domains of chemokine receptors are not responsible for signaling specificity ([@bib62]). In this work, the extracellular and transmembrane domains of rhodopsin were combined with the intracellular domains of Cxcr4. In this case, in response to light (the ligand of rhodopsin), the chimeric protein elicited Cxcr4 signaling, such that it could direct the migration of T-cells. A receptor could show signaling bias by preferentially activating different signaling cascades depending on the specific ligand or agonist it binds. For example, when chemokine receptor Ccr7 is bound by Ccl19, it induces β-arrestin recruitment more potently than when it is bound by Ccl21 ([@bib25]). Another type of signaling bias, which could increase the range of processes that chemokine receptors control involves the initiation of different signaling cascades upon binding of the same ligand. For example, Cxcr4 interaction with its ligand Cxcl12 triggers both Gαi and β-arrestin signaling ([@bib12]; [@bib55]; [@bib58]), while Cxcr7 receptor interaction with Cxcl12 was reported to activate β-arrestin but not G-protein signaling ([@bib47]). Overall, the above-mentioned studies help explain how chemokine receptor signaling bias occurs, as these receptors and their ligands can differentially activate certain second messengers. However, previous studies have not thoroughly examined the relevance of specific differences in second messenger activation with respect to the resulting biological responses *in vivo*.

Here, we demonstrate that distinct responses to chemokine receptor signaling depend on the responding cell type rather than on the specific receptor activated by its ligand. We demonstrate this principle via chemokine receptor signaling in zebrafish embryos by examining the function of four different chemokine receptors: Cxcr4a, Cxcr4b, Ccr7, and Ccr9. We gathered several lines of evidence to show that these chemokine receptors initiate specific biological processes in a way that depends on the cell types they are expressed in. These results present chemokine receptor signal interpretation module (CRIM) as a new mechanism for biasing the biological response resulting from chemokine receptor signaling. Specifically, we showed that each of those receptors is capable of controlling biological processes that it normally does not regulate, indicating that different chemokine receptors provide the same signal when activated. We thus suggest that different cell types express specific response modules or CRIM that interpret generic signals produced by different types of chemokine receptors.

Results {#s2}
=======

The signaling cascades initiated by Cxcr4a and Cxcr4b can direct similar biological processes {#s2-1}
---------------------------------------------------------------------------------------------

As a result of an additional genome duplication in teleosts relative to other vertebrates ([@bib31]; [@bib37]), the zebrafish genome encodes two *cxcr4* genes, specifically *cxcr4a* and *cxcr4b* ([@bib7]). These two genes were shown to regulate very different biological events and respond to different ligands; Cxcr4a is activated by the chemokine Cxcl12b and Cxcr4b is activated by the chemokine Cxcl12a ([@bib2]). Cxcr4a plays a central role in vascular system patterning by guiding multicellular vessel growth ([@bib52]). Additionally, Cxcr4a controls endodermal cell-matrix adhesion, thereby ensuring proper gastrulation movements ([@bib41]). At the same time, Cxcr4b is involved in different processes such as the guided migration of primordial germ cells (PGCs) ([@bib10]; [@bib24]). To examine whether qualitative differences between Cxcr4a and Cxcr4b signaling exist, we investigated this issue in the contexts of gastrulation (Cxcr4a-controlled endodermal cell adhesion) and directional migration (Cxcr4b-controlled single-cell migration).

First, we expressed Cxcr4a instead of the Cxcr4b receptor in PGCs and examined whether the foreign receptor (Cxcr4a) could function in the context of guided single-cell migration, which is normally directed by Cxcr4b. We assayed the function of the receptor by monitoring the position of the PGCs in 12 hours post-fertilization (hpf) old embryos, a stage when *cxcl12b* (encoding for the Cxcr4a ligand) and *cxcl12a* (encoding for the Cxcr4b ligand) exhibit distinct expression patterns ([@bib2]), allowing us to determine the response of the cells towards each of the ligands. In this experimental setup, embryos homozygous for the *cxcr4b odysseus* nonsense mutation, inactivating the gene ([@bib24]) were used. In *odysseus* mutant embryos injected with control RNA encoding for the human CD14 the PGCs were randomly distributed, whereas injecting RNA encoding for Cxcr4b in the PGCs reversed the phenotype, such that the cells clustered at regions where the ligand Cxcl12a was expressed ([Figure 1A](#fig1){ref-type="fig"}). Intriguingly, PGCs expressing Cxcr4a were located closer to the midline at the region where the RNA encoding for the Cxcr4a ligand Cxcl12b is normally expressed (see green label in [Figure 1A](#fig1){ref-type="fig"} right panel, n = 60 embryos in three experimental repeats). Thus, the mis-expressed chemokine receptor Cxcr4a is capable of directing PGC migration toward sites where its ligand Cxcl12b is expressed, despite the fact that it is normally not involved in this process. This result is consistent with the idea that the signals provided by the two receptors are qualitatively similar, allowing the cells to respond in a similar way to the signals generated by either of the receptors.

![The signaling cascades initiated by Cxcr4a and Cxcr4b are functionally equivalent.\
(**A**) The position of PGCs (detected by *nanos3* RNA expression, yellow) relative to tissues expressing *cxcl12a* (magenta) and *cxcl12b* (green) RNAs in 12 hpf *cxcr4b-/-* embryos. PGCs express *control* RNA (*cntl*, left panel) or RNAs encoding for Cxcr4b (middle panel) or Cxcr4a (right panel). 20 pg of *control* RNA and RNA encoding for Cxcr4a and Cxcr4b were injected. (**B**) Epifluorescence image of transgenic *sox17::gfp* embryos at 8 hpf. The embryos were injected with control (cntl) morpholino and *control* RNA (left panel). Experimental embryos were knocked down for Cxcr4a and Cxcl12b and the effect of *control* RNA, *cxcr4a* and *Cxcl12b* or *cxcr4b* along with *cxcl12a* mRNAs was examined. The quantitation of the endoderm displacement with respect to the forerunner cells is presented in the graph on the right. See also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}. 0.8 pmol of each morpholino was used. 100 pg of receptor and 50 pg of ligand encoding mRNA was used, as well as equimolar amounts of *control* RNA.\
10.7554/eLife.33574.005Figure 1---source data 1.Source data file contains the results of the measured displacement of endoderm from forerunner cells under different experimental conditions.The data shows that the expression of Cxcr4b together with Cxcl12a can reverse the phenotype of displaced endoderm in Cxcr4a morphants. Three biological replicates are presented.](elife-33574-fig1){#fig1}

To further investigate if the signals the two receptors elicited were indeed equivalent, we examined the ability of Cxcr4b to support a process normally controlled by Cxcr4a and its ligand Cxcl12b, namely the proper adhesion and positioning of endodermal cells during gastrulation. In this experiment, we made use of a transgenic fish line (*sox17::GFP,* \[[@bib38]\]) in which all the endodermal cells and the dorsal forerunner cells are labeled with GFP. Inhibiting the translation of *cxcr4a* along with *cxcl12b* RNAs using antisense morpholino oligonucleotides elicited the previously described abnormal displacement of endoderm from the dorsal forerunner cells, as seen in [Figure 1B](#fig1){ref-type="fig"} ([@bib41]). Unlike the case of chemokine-guided migration, in the context of controlling the interaction of the endoderm with the mesoderm, the distribution of the ligand is not critical. Accordingly, global expression of the chemokine acting in a paracrine or autocrine manner is expected to effectively control the process. Indeed, the *cxcr4a/cxcl12b* morpholino--induced phenotype was effectively rescued by co-expressing the morpholino-resistant *cxcr4a* and *cxcl12b* mRNAs in the embryos ([Figure 1B](#fig1){ref-type="fig"}). Interestingly, consistent with the idea that the intracellular signals generated by the two receptors are equivalent, the expression of *cxcr4b* and c*xcl12a* RNAs in embryos knocked down for *cxcr4a* and *cxcl12b* reversed the phenotype as well. Thus, Cxcr4b signaling in endodermal cells could effectively replace that of Cxcr4a as determined by the reduction in the displacement between endodermal cells and forerunner cells.

CC chemokine receptors can control processes regulated by CXC receptors {#s2-2}
-----------------------------------------------------------------------

The results presented above show that distinct CXC receptors can control processes they are not normally involved in. Nevertheless, Cxcr4a and Cxcr4b show relatively high similarity in their protein sequence ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Therefore, to examine the equivalence of chemokine receptor signaling more rigorously, we performed analogous experiments where we exchanged CC and CXC receptors in different processes. Here, Ccr9 and Ccr7 (and their ligands Ccl25 and Ccl19, respectively), which do not share high-sequence similarity with Cxcr4a, Cxcr4b ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}) were tested in the context of Cxcr4-controlled PGC directional migration and endoderm cell adhesion.

To examine the general nature of chemokine receptor signals, we tested the potency of Ccr7 and Ccr9 in regulating endodermal cell movement. We expressed these receptors with their cognate ligands in early embryos and observed their effects on endodermal cell positioning in the embryos knocked down for Cxcr4a, the receptor that normally regulates this process. The ubiquitous expression of chemokine receptors and their ligand in the early embryos by way of injecting the RNA results in a uniform expression pattern, which in the context of this process is similar to that of the endogenous receptor-ligand pair (Cxcr4a and Cxcl12b).

Remarkably, both Ccr9 and Ccr7 reversed the Cxcr4a phenotype concerning the displacement between endoderm cells and dorsal forerunner cells, effectively controlling endodermal cell positioning ([Figure 2A,B](#fig2){ref-type="fig"})

![CC receptors can control a process regulated by CXC receptors.\
(**A**) Epifluorescence image of *sox17::gfp* transgenic control embryos (left panel) and embryos knock down for Cxcr4a. The Cxcr4a knocked down embryos were injected with *control* RNA (*cntl*) or with *cxcr4a* RNA, or co-injected with *ccr9* RNA and its ligand *ccl25* RNA. The quantitation of the endoderm displacement with respect to the forerunner cells is presented in the graph on the right. See also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}. (**B**) Epifluorescence image of *sox17::gfp* transgenic control embryos (left panel) and of embryos knocked down for Cxcr4a. The embryos were injected with *control* RNA, with *cxcr4a* RNA, or co-injected with *ccr7* RNA and its ligand *ccl19* RNA. The quantitation of the endoderm displacement with respect to the forerunner cells is presented in the graph on the right. 0.8 pmol of each morpholino was used. 100 pg of receptor and 50 pg of ligand encoding mRNA was used, as well as equimolar amounts of control RNA.\
10.7554/eLife.33574.009Figure 2---source data 1.Cxcr4b can initiate signaling cascade functionally equivalent to Cxcr4a in endoderm cells.Source data contains two files, Figure 2---source data 1A contains the results of the measured displacement of endoderm from forerunner cells under different experimental conditions. The data shows that the expression of Ccr9 together with Ccl25 can reverse the phenotype of displaced endoderm in Cxcr4a morphants. Figure 2---source data 1B contains data showing that expression of Ccr7 together with Ccl19 can reverse the phenotype of displaced endoderm in Cxcr4a morphants. Three biological replicates are presented for both the experiments.](elife-33574-fig2){#fig2}

To further test the capability of receptors to direct cell migration, we expressed receptors in PGCs and their cognate ligands in one half of the embryo in the absence of the regular endogenous signals guiding the cells (i.e. the Cxcl12a in the environment and Cxcr4b in the PGCs). In this experimental setup, we thus generated spatially restricted source of chemokine, simulating the uneven distribution of the endogenous guidance cue within the embryo (see [Figure 3](#fig3){ref-type="fig"} for a schematic representation of the experimental setup). If the receptor can direct cell migration, it would lead to PGC accumulation within the part of the embryo expressing the ligand, as compared with a random distribution in control ([@bib10]). Interestingly, in contrast with PGCs expressing control RNA that were randomly distributed throughout the embryo, under conditions where the endogenous Cxcl12a signals were knocked down, PGCs expressing Ccr9 were preferentially present on the part of the embryo engineered to express Ccl25 ([Figure 3A,C](#fig3){ref-type="fig"}). Similar results were observed when testing the activity of Ccr7 and its ligand Ccl19 ([Figure 3A,D](#fig3){ref-type="fig"}) and Cxcr4a and its ligand Cxcl12b ([Figure 3A,B](#fig3){ref-type="fig"}), demonstrating that receptors from the same and from different families can control directional PGC migration.

![CC and CXC receptors can direct the migration of primordial cells.\
The experimental scheme is provided at the top. (**A**) Epifluorescence image of 10 hpf embryos expressing the *control* RNA or RNA encoding for the indicated ligand (Cxcl12a, Cxcl12b, Ccl25 and Ccl19) in one half of the embryo and *control* RNA or Receptor-encoding RNA (Cxcr4b, Cxcr4a, Ccr9 or Ccr7) in PGCs. Merged images show the position of PGCs with respect to control or ligand-expressing domains (red). (**B--D**) Graphs show the quantitation of the migration of PGCs as the percentage of GFP-labeled cells located within the ligand-expressing part of the embryos. 60 pg of *mGFP-nanos* was used to label PGCs in green and 40 pg of *m-cherry* mRNA was used for labeling the ligand expressing half of the embryo. 20 pg of receptor-encoding RNA was used and 30 pg of ligand-encoding RNA was used. 0.2 pmol of Cxcl12a morpholino was used. Equimolar amounts of control RNA were used. For raw data see [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}.\
10.7554/eLife.33574.013Figure 3---source data 1.The data presents the percentage of PGCs located on the ligand expressing embryo half under conditions where the Cxcr4b and Cxcl12a proteins are not expressed.Figure 3---source data 1B contains data showing that Cxcr4a can direct PGCs towards the Cxcl12b-expressing half. Figure 3---source data 1C contains data showing that Ccr9 can direct PGCs toward the Ccl25 expressing half. Figure 3---source data 1D contains data showing that Ccr7 can direct PGCs toward Ccl19 expressing half. Three biological replicates are presented for each experiment.](elife-33574-fig3){#fig3}

Different chemokine receptors can control dorsoventral axis specification {#s2-3}
-------------------------------------------------------------------------

Since the biological contexts studied above are based on cell migration, we further tested the equivalency of chemokine receptor signals in the context of dorsoventral fate specification in the early zebrafish embryo. Ccr7 was previously shown to be important for dorsoventral axis specification in early zebrafish embryos ([@bib61]). Here, the activated Ccr7 limits β-catenin-induced dorsalization throughout the early embryo, thereby controlling the relative size of dorsal and ventral domains. Embryos lacking Ccr7 function (maternal zygotic *ccr7^stl7/stl7^*, MZ*ccr7* mutants) do not appear morphologically dorsalized as do *ccr7* morpholino-treated embryos ([@bib61]), a finding that could be attributed to off-target effects of the morpholinos on genes in addition to *ccr7*. Nevertheless, MZ*ccr7* mutant embryos do exhibit increased sensitivity to β-catenin-induced dorsalization. Consequently, a very low dose of RNA encoding for Δβ-catenin (2.5 pg) caused expansion of the dorsal region in MZ*ccr7* homozygous mutants, whereas in wild-type embryos the same dose of Δβ-catenin has no effect ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

To quantify the effect of chemokine signaling on the size of the dorsal tissue induced by Δβ-Catenin, we used MZ*ccr7* mutant embryos expressing GFP under the control of the *goosecoid* promoter ([@bib10]). We counted the number of pixels showing GFP expression above the auto threshold in those embryos following different experimental manipulations. MZ*ccr7* mutants *Δβ-catenin* RNA-sensitized embryos co-injected with *control* RNA showed high level of GFP expression at 5 hpf as compared with non-injected embryos ([Figure 4A--D](#fig4){ref-type="fig"}). Interestingly, *goosecoid* promoter-driven GFP expression was reduced in *Δβ-catenin* RNA-sensitized MZ*ccr7 embryos* in which different chemokine receptors were activated by expression of *cxcr4a*, *cxcr4b* and *ccr9* RNAs along with their cognate ligands ([Figure 4A--D](#fig4){ref-type="fig"}). These results show that Ccr7's effect on the extent of dorsalization ([@bib61]) can be directed by other chemokine receptors from different families.

![Control of dorsoventral axis specification by different chemokine receptors.\
(**A**) Epifluorescence image of 5 hpf *ccr7-/-* mutant embryos carrying the *gsc::gfp* transgene. Uninjected embryo (left panel) and embryos sensitized by injection of Δβ-Catenin encoding RNA (right panels) are presented. The embryos were also injected with *control* RNA (*cntl*) or with RNA encoding for different chemokine receptors (Cxcr4a, Cxcr4b or Ccr9) and their cognate ligands (Cxcl12b, Cxcl12a or Ccl25). (**B--D**) Graphs showing the area of the *goosecoid* expression domain determined by quantifying the number of pixels with GFP signal above the auto threshold in the different treatments. 100 pg of mRNA encoding for the receptors was injected and 60 pg of RNA encoding for the ligands. 2.5 pg of Δβ-Catenin-encoding RNA was inject to sensitize the embryos. Equimolar amounts of *control* RNA were used. For raw data see [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}.\
10.7554/eLife.33574.017Figure 4---source data 1.The data presents the number of pixels showing GFP expression above the threshold (Area of *goosecoid* RNA expression) in embryos under different experimental conditions.Figure 4---source data 1B shows that expression of Cxcr4a together with Cxcl12b lead to a reduction in the area of *goosecoid* expression. Figure 4---source data 1C shows that expression of Cxcr4b together with Cxcl12a lead to a reduction in the area of *goosecoid* expression. Figure 4---source data 1D shows that expression of Ccr9 together with Ccl25 lead to a reduction in the area of *goosecoid* expression. A minimum of three biological replicates are presented for each experiment.](elife-33574-fig4){#fig4}

Different chemokine receptors activate the same downstream signaling pathway to direct cell migration {#s2-4}
-----------------------------------------------------------------------------------------------------

In contrast to the notion that different receptors initiate different signaling cascades to mediate various biological processes, our results suggest that different chemokine receptors initiate similar signaling. Accordingly, the specific response to receptor signaling might depend on its interpretation by the cell type within which the receptor was activated. To test this idea, we examined the signaling downstream of chemokine receptors in the context of directional cell migration.

Cxcr4 was shown to signal through Gαi in response to Cxcl12 binding ([@bib39]). Accordingly, Gαi was shown to be important for Cxcr4b-mediated directed PGC migration in zebrafish ([@bib12]). To examine if the guidance signals that receptors other than Cxcr4b transmitted are Gαi dependent as well, we expressed pertussis toxin (PTX) in the PGCs. PTX catalyzes ADP ribosylation of Gαi impairing its interaction with the receptor thereby inhibiting G-protein-dependent signaling ([@bib5]; [@bib35]). We examined if this treatment that inhibits Gαi signaling affected the activity of different chemokine receptors in steering PGCs toward ligand-expressing domains within the embryo ([Figure 5A](#fig5){ref-type="fig"}). Indeed, the guidance of PGCs mediated by the four receptor-ligand pairs (Cxcr4b-Cxcl12a, Cxcr4a-Cxcl12b, Ccr9-Ccl25 and Ccr7-Ccl19) was abrogated by inhibiting Gαi function ([Figure 5A--E](#fig5){ref-type="fig"}). These results are consistent with the idea that Gαi is essential for the directional cues the four chemokine receptors provide to the motile PGCs.

![CC and CXC receptors can regulate the migration of primordial cells employing the same downstream signaling pathway.\
(**A**) Epifluorescence image of 10 hpf embryos expressing different ligands (Cxcl12a, Cxcl12b, Ccl25 and Ccl19) in one half of the embryo (mCherry-expressing cells) and PGCs (mGFP) expressing different chemokine receptors (Cxcr4b, Cxcr4a, Ccr9 and Ccr7) along with PTX. Merged images show the position of PGCs with respect to control (*cntl*), or ligand-expressing cells. (**B--E**) Graphs showing the quantitation of directed cell migration, by presenting the percentage of PGCs located within the ligand-expressing domains. 60 pg of *mGFP-nanos* was used to label PGCs in green and 40 pg of *m-cherry-globin* mRNA was used for labeling the ligand-expressing half of the embryo. 10 pg of PTX-encoding RNA were injected to inhibit the Gi protein. 20 pg of receptor-encoding RNA was used and 30 pg of ligand-encoding RNA was used. 0.2 pmol of cxcl12a morpholino was used. Equimolar amounts of *cntl* RNA were used. For raw data see [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"} .\
10.7554/eLife.33574.021Figure 5---source data 1.The data presents the percentage of PGCs expressing pertussis toxin present on ligand expressing embryo half.Figure 5---source data 1B shows that Cxcr4b cannot direct PGCs expressing PTX towards the Cxcl12a expressing half. Figure 5---source data 1C shows that Cxcr4a cannot direct PGCs expressing ptx toward the Cxcl12b expressing embryo half. Figure 5---source data 1D shows that Ccr9 cannot direct PGCs expressing PTX toward the Ccl25 expressing embryo half. Figure 5---source data 1E shows that Ccr7 cannot direct PGCs expressing ptx toward Ccl19 expressing embryo half. Minimum of three biological replicates are presented for each experiment.](elife-33574-fig5){#fig5}

The finding that different types of chemokine receptors depend on the same signaling cascade to control the same process highlights the importance of tight regulation over their expression. This would ensure that distinct processes are regulated by the specific ligands that are expressed at the correct time and location. To demonstrate this point, we ectopically expressed the Cxcr4a receptor in the PGCs rendering them responsive to its cognate ligand Cxcl12b (in addition to the endogenous Cxcr4b ligand Cxcl12a). Interestingly, despite the expression of Cxcl12a within regions toward which the PGCs migrate, making the cells responsive to Cxcl12b affected their migration. Specifically, we found that PGCs co-expressing the two chemokine receptors were more dispersed within the embryo, consistent with the idea that they responded to spatially distinct conflicting signals encoded by the two different ligands. Indeed, PGCs could be found in locations (e.g. in the head region, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) where Cxcl12b is expressed ([@bib57]).

Compensation between G-protein-coupled receptors from different groups {#s2-5}
----------------------------------------------------------------------

The results provided above support the notion that chemokine receptors from different groups can initiate the same signaling pathways. These findings raise the possibility that chemokine receptors in a particular cell type may act redundantly among themselves or with receptors belonging to other GPCRs classes to control specific processes, thereby conferring genetic robustness ([@bib27]). According to this proposition, receptors that are not considered to play a role in certain processes since their function appears dispensable for them, are actually important for those events, but are redundant.

To examine this proposition, we studied the role of two classes of GPCRs expressed during early stages of embryogenesis in a process where they were not known to function before. We analyzed the involvement of the chemokine receptor Cxcr4b and phospholipid receptors (S1p and LPA receptors) in the process of gastrulation. To this end, we overexpressed LPPs (lipid phosphate phosphatases), which dephosphorylate active lipids such as S1p and LPA, a treatment that should reduce signaling by lipid receptors Lpar and S1pr ([@bib3]). Conducting this treatment in embryos lacking Cxcr4 function allows for studying the effect of simultaneous inhibition of two seemingly unrelated receptors.

Overexpression of LPPs in WT embryos had no visible effect on gastrulation and development ([Figure 6A](#fig6){ref-type="fig"}). Interestingly, however, overexpression of LPPs in *cxcr4b* mutant embryos led to a strong delay in epiboly movements ([Figure 6A and B](#fig6){ref-type="fig"}) and somitogenesis as compared with a similar manipulation in wild-type embryos ([Figure 6C and D](#fig6){ref-type="fig"}). These results are consistent with the idea that the two unrelated receptors, despite belonging to different groups of GPCRs, cooperate in ensuring proper progression of early processes in early embryonic development.

![Functional compensation between G-protein-coupled receptors from different groups.\
(**A**) Brightfield images showing 10 hpf embryos overexpressing RNA encoding for LPPs (lpp1-varX1, lpp3-varX1) or *control* RNA. Wild-type (WT) embryos overexpressing Lpps and embryos lacking Cxcr4b function (*cxcr4b-/-)* developed normally. Cxcr4b-deficient embryos overexpressing Lpps exhibited a delay in gastrulation and failed to close the yolk plug. (**B**) Graph showing the percentage of embryos with closed yolk plug between 9.75 and 11 hpf. (**C**) Brightfield images of embryos at 12 hpf. WT embryos overexpressing Lpps and embryos lacking Cxcr4b function (*cxcr4b-/-)* developed normally and formed six somites by this stage. Embryos lacking Cxcr4b function (*cxcr4b^-/-^*) that overexpress Lpps developed only five somites that appear abnormal. (**D**) Graph showing the number of somites at 12 hpf in WT and *cxcr4b^-/-^* embryos expressing control or Lpps encoding RNA. 75 pg of RNA encoding each Lpp was injected. Equimolar amounts of *control* RNA were used. For raw data see [Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"}.\
10.7554/eLife.33574.023Figure 6---source data 1.GPCRs from different groups cooperate during gastrulation and somitogenesis.[Figure 6---source data 1B](#fig6sdata1){ref-type="supplementary-material"} contains data showing the proportion of *cxcr4b-/-* and WT embryos expressing *control* or *lpps* RNA that completed gastrulation between 9.5 hpf and 11 hpf. [Figure 6D---source data 1](#fig6sdata1){ref-type="supplementary-material"} presents data showing the number of somites in *cxcr4b-/-* and WT 12 hpf embryos expressing *control* or *lpps* RNA. Three biological replicates are presented for each experiment.](elife-33574-fig6){#fig6}

PGCs perform reverse migration upon exposure to high levels of the attractant Cxcl12a {#s2-6}
-------------------------------------------------------------------------------------

According to our findings, chemokine-induced signaling elicits a qualitatively similar cascade that is interpreted differently by different types of cells. At the same time, a specific cell type can interpret chemokine signals in a distinct way that is dictated by the specific chemokine receptor signal interpretation module (CRIM). For example, if a chemokine receptor-induced signaling cascade leads to directional migration toward a ligand, the same signaling cannot induce migration away from the source of ligand in the same cell type ([@bib45]). However, our model appears to be incompatible with cell behavior during fugetaxis (cell movement away from the chemoattractant \[[@bib59]\]), and retrotaxis (cell migration down chemoattractant gradients \[[@bib20]\]). Relevant for the guided migration of PGCs, T-cells were shown to actively migrate away from high concentrations of Cxcl12 ([@bib45]).

To examine the behavior of PGCs upon exposure to a high concentration of a ligand, simulating the conditions the cells would experience upon arrival at their target, we expressed the ligand in the forming endoderm of the embryo. This was achieved by co-injecting RNA encoding for the activated version of the TARAM-A receptor (TARAM-A\*,\[[@bib44]\]) with RNA encoding for the Cxcl12a into one blastomere at the 16-cell stage embryo. In this experiment, we expressed low (25 pg) and high (400 pg) amounts of *cxcl12a* in endoderm and observed the behavior of Cxcr4-expressing PGCs in a 10 hpf embryo.

As expected, the PGCs were found to be located on the Cxcl12a-expressing area when the level of the ligand was low ([Figure 7A](#fig7){ref-type="fig"}, [Figure 7---Video 1](#fig7video1){ref-type="video"}), they continued to migrate within this region and only very rarely would leave the Cxcl12a-expressing domain ([Figure 7B and C](#fig7){ref-type="fig"}). Surprisingly, unlike the behavior PGCs exhibited with respect to low-Cxcl12a-expressing domains, when high levels of the ligand (400 pg) were expressed, the PGCs were not localized within the area where the ligand was expressed ([Figure 7A](#fig7){ref-type="fig"}). Instead, the cells initially actively migrated toward ligand-expressing area, but often turned away from the region where the ligand was expressed, a behavior resembling reverse migration, as observed, for example, for neutrophils at a resolution phase of inflammation ([@bib9]; [@bib36]) [Figure 7B](#fig7){ref-type="fig"}, [Figure 7---Video 2](#fig7video2){ref-type="video"}.

![Regulation of reverse migration of PGCs by receptor internalization.\
(**A**) Tracks of PGCs with respect to domains in the embryo expressing low or high levels of Cxcl12a, in embryos lacking the endogenous ligand. PGCs migrated into domains expressing low levels of the attractant and remained within them, while the cells turned away when the domains expressed high levels of Cxcl12a. (**B**) Graph showing percentage of cells that moved away from the Cxcl12a expressing domains (2.6% in the case of low Cxcl12a expression and 57.1% in the case of high Cxcl12a levels). (**C**) Graph showing the percentage of cells that remained for 90 minutes or more within the Cxcl12a expressing area 97.4% in the case of the low expression of the chemokine and 12.2% in the case of high Cxcl12a expression). (**D**) High-magnification images of PGCs expressing EGFP-tagged Cxcr4b and farnesylated mCherry on their membranes. The cells interacted with low and high Cxcl12a expressing domains as in A. (**E**) Graph showing the level of Cxcr4b on the PGC membrane as a ratio between the EGFP signal and that of the farnesylated mCherry in cells exposed to low and high concentrations of the ligand. 20 pg of *cxcr4b-nanos,* 400 pg and 25 pg of *cxcl12a* RNA was injected to achieve high and low expression domains; 60 pg of *mGFP-nanos* was used to label the PGCs; 30 pg of *m-cherry-H2B* was used to label the cells expressing Cxcl12; and 2 pg of *TARAM-A\**. 101 pg of *cxcr4b-EGFP-nanos* was used in the receptor internalization assay and 60 pg of *m-cherry-nanos* was used to label the membrane of PGCs. 0.2 pmol of Cxcl12a morpholino was used. Equimolar amounts of *control* RNA were used. For raw data see [Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"}.\
10.7554/eLife.33574.027Figure 7---source data 1.PGCs undergo reverse migration upon exposure to high amount of chemoattractant.Figure 7---source data 1A,B,C contains data from 180 min long time-lapse movies. The data represent number of PGCs that turned away or remained within the Cxcl12a expressing region. 1 out of 16 blastomeres was injected with high (400 pg) or low (25 pg) amounts of RNA encoding for Cxcl12a as well as with RNA encoding for the activated version of TARAM-A that direct the cells to the endodermal lineage. Figure 7---source data 1E presents the intensity of the mcherry F' signal and Cxcr4b-EGFP signal on the membrane of PGCs exposed to the low or high amount of Cxcl12a. A minimum of three biological replicates are presented for each experiment.](elife-33574-fig7){#fig7}

Since PGCs performed reverse migration only when exposed to a high concentration of the ligand, we reasoned that rapid receptor internalization due to exposure to high levels of the ligand could lead to this behavior. According to this model, when cells reach the location of high ligand concentration, they can move away as they lost the ability to respond to the chemokine signal and migrate randomly. To examine this possibility, we compared the effect of ligand concentration on the levels of the Cxcr4b receptor on the membrane of PGCs. To this end, we labeled the PGC membrane with mCherry, and compared this signal with that of an EGFP-tagged Cxcr4b. The ratio between the mCherry and the EGFP signals reported the relative amount of functional receptor present on the membrane of the cell. Indeed, PGCs exposed to a high concentration of the ligand retained significantly fewer receptors on their membranes as compared with PGCs exposed to a low concentration of the ligand ([Figure 7D and E](#fig7){ref-type="fig"}). Thus, the level of receptor internalization could be correlated with reverse migration and could constitute the basis for this behavior.

Discussion {#s3}
==========

In this work, we show that the same chemokine receptor can direct distinct responses in different cell types, while different receptors elicit the same biological response in a specific type of cells. These findings are consistent with the idea, that the biological consequences of chemokine receptor signaling depend on the cell type rather than on qualitative differences in the signal produced by specific receptors. We demonstrate that the identity of the activated receptor is immaterial for the actual interpretation of the signal that results in distinct biological responses in different cells. Our findings suggest that based upon their specific differentiation state, different cell types contain specific chemokine receptor signal interpretation modules (CRIM) that interpret the generic signals produced by chemokine receptors. The suggestion that the same receptor can elicit different cellular responses is presented graphically in [Figure 8A](#fig8){ref-type="fig"}. While it is possible that different receptors induce the response more efficiently or less, the qualitative features of the signaling, at least for the receptors and processes we examined, appear to be generic. Consistently, the cell-specific biological response to the signal appears to be robust as it can be observed when different levels of the receptor were expressed in the cells ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). This situation is analogous to heterozygosity for mutated chemokine and chemokine receptor alleles that has no phenotypic consequences ([@bib24]; [@bib29]), as well as to a situation where the level of the Cxcr4b and Cxcl12a is altered by alleviating the miRNA regulation, a manipulation that has no phenotypic consequences ([@bib18]).

![Graphical representation of Chemokine Receptor-signal Interpretation Module (CRIM).\
(**A**) Graphical summary of results. (**B**) Schematic representation of concurrent trafficking of different cell types possessing identical CRIM and expressing different chemokine receptors.](elife-33574-fig8){#fig8}

In support of our model, it was shown that in the context of the immune system the same cell type can respond in a similar way to signaling of different chemokine receptors. For example, CCR1, CXCR1 and CXCR2 were shown to trigger arrest of rolling monocytes ([@bib30]; [@bib33]; [@bib60]). An interesting feature of the model we propose is that it allows positioning of cells by different ligands expressed in spatially distinct locations. Such a scenario was described in the case of neutrophil mobilization from the bone marrow to the blood stream and is schematically presented in [Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}. In this case, the positioning of the cells is dictated by a tug-of-war situation in which CXCL12 expressed by osteoblasts functions as a retention signal that maintains the neutrophils within the bone and CXCL2 emanating from the endothelium that attracts the cells toward the blood vessels ([@bib13]). Another aspect of the model is presented schematically in [Figure 8B](#fig8){ref-type="fig"}. In this case, concurrent trafficking of different cell types to distinct locations can be achieved using different chemokines. For example, in humans two subsets of memory T-cells, central memory T cells (T~CM~, CCR7^+^) and effector memory T-cells (T~EM,~ CCR7^--^) exhibit different behavior and localization. T~CM~ tend to home to secondary lymphoid organs, where ligand for CCR7 is expressed, whereas TEM, that express CCR1, CCR3, CCR5 migrate toward the inflamed tissue, where the corresponding ligands for those receptors are expressed ([@bib49]). Thus, while several cell types share CRIMs, their actions are compartmentalized by dynamic and distinct spatiotemporal expression patterns of the receptors and their cognate ligands.

In the context of embryonic development, the differentiation of cells and tissues dictates the presence of specific downstream signaling molecules in different cell types, which facilitates differential interpretation of a generic signal generated by chemokine receptors. This differential cell competence allows concomitant processes to be controlled by chemokines by regulating the expression pattern of receptors and ligands in specific cell populations. For example, during zebrafish gastrulation Cxcr4a regulates endodermal cell movement by controlling adhesion levels in response to uniform chemokine signaling. At the same time, the migration of germ cells is directed by specific patterns of a different ligand that interact with the chemokine receptor Cxcr4b. These two different events can take place at the same time within the same region of the embryo despite the generic signal the receptors produce as the different cell types interpret it differently.

A particular feature of the generic downstream signaling is to increase the robustness of physiologically important processes through cooperation between different receptors in supporting specific processes. For example, by inhibiting the function of lipid-activated GPCRs, we revealed a novel function of Cxcr4 in promoting epiboly during gastrulation. This function was not described before, as Cxcr4 function is redundant to that of the LPA and S1P receptors. Similarly, T cells utilize Ccr9, Cxcr4 and Ccr7 for homing to the thymus in early mouse embryos, but eliminating the function of one or two of these receptors is not sufficient to abrogate thymus homing. Only in the absence of all three receptors is thymic homing of T-cells completely abolished ([@bib4]). The implication of these findings is that to determine the role of chemokine signaling in a certain process, one should mutate all the chemokine receptors/GPCRs in a tissue. Our findings suggest that even if cells express multiple chemokine receptors, at a specific differentiation or physiological state they can respond to receptor activation in only one way, such as directed migration ([@bib10]), interaction with other cell types ([@bib41]) or embryonic patterning ([@bib61]). As S1P/LPA receptors and Cxcr4b were able to elicit a similar biological response ([Figure 6](#fig6){ref-type="fig"}), this principle could be relevant for other G-protein-coupled receptors. Indeed, G-protein-coupled receptors of different families were shown to result in similar responses in other contexts. For example, neutrophils were shown to migrate towards fMLP and Cxcl8, ligands that bind distinct receptors ([@bib15]; [@bib32]). Interestingly, despite the fact that the receptors for these ligands (fMLP receptor and Cxcr2, respectively) differ in some different downstream effectors they activate, the response to ligand binding is qualitatively identical ([@bib21]). Thus, despite differences in the biochemical response to such signals, the specific biological response of a specific cell type is identical.

In light of our findings, chemokine-mediated attraction, fugetaxis or retrotaxis do not represent the activation of distinct signaling pathways. We suggest that reverse migration does not involve a qualitatively different signaling pathway, but represents a lack of receptor signaling due to internalization and desensitization processes, as proposed by Holmes and colleagues based on mathematical modeling ([@bib22]). In contrast, cells that encounter regions where lower levels of the ligand are expressed maintain the receptor on their membranes and are therefore retained within those regions by positively responding to the chemokine distribution in the tissue. It would be interesting to determine if in other cases where retrotaxis was described for example in the case of LXA4 ([@bib20]), which has also been shown to act as a potent chemoattractant ([@bib34]), G-protein-coupled receptor internalization or desensitization of signaling provides the basis for reverse migration.

While we present here a role for a chemokine receptor signal interpretation modules (CRIM) in a range of biological process in the context of different receptors function, some previous findings report on qualitatively different responses in the same cell type ([@bib16]). Such cases do not necessarily contradict our model if the cells investigated undergo a maturation process, which alter their interpretation of the signal. We suggest that since, among other differences, specific cell types differ from one another by the specific response network they harbor, the outcome of chemokine signaling can differ between cells of different lineages and sublineages (see [Figure 8---figure supplement 1B](#fig8s1){ref-type="fig"} for a graphical explanation of the concept). Apparently differential response to chemokine signaling was demonstrated in the case of leukocyte arrest in response to CXCL1 activation of CXCR2, while CCL2 binding to CCR2 could not lead to a similar biological response in the same cell type ([@bib23]). These findings are, however, contradictory to another study according to which CCL2 could actually induce leukocyte arrest ([@bib16]). It would thus be interesting to critically examine such contrasting results in light of the model we suggest. Similar statements suggesting different biological responses elicited by the action of distinct ligands (e.g. \[[@bib65]\]) should be carefully assessed for equal experimental starting conditions and cell states between the different treatments.

While the principle of generic signals and cell-specific interpretation presented here was tested in the context of chemokine receptors, it could also be relevant for other receptor families such as receptor tyrosine kinases. For example, for the receptor tyrosine kinase EGFR, the same ligand was shown to control different biological processes upon activating a specific receptor within different cell types ([@bib14]; [@bib46]). Similarly, activation of the G-protein-coupled receptor for Acetylcholine was shown to induce different biological responses in different cell types ([@bib6]). Such findings were interpreted as an indication that the same signaling pathway can lead to multiple cellular and developmental consequences, depending on the context and time ([@bib14]).

While based on our results chemokine receptors elicit qualitatively similar signals, which appear to be equivalent to those LPA and S1P receptors produce, the signal may not be universal for all GPCRs. Indeed, the endoderm migration defect resulting from loss of Apela, a GPCR ligand ([@bib43]) could not be suppressed by expression of Cxcr4b or CCR9 with their corresponding ligands (data not shown). Further experiments should be conducted to determine if this finding reflects a qualitative difference between the signal the chemokine receptors produce and the receptor for Apela. Alternatively, the dynamics of the expression of Apela and its receptor, which we could not mimic by uniformly expressing receptors and their ligands is responsible for this result.

Our findings suggest that in addition to the expression of classic cell-specific differentiation markers, an important aspect of cell specification that dictates its fate and behavior is the expression of signaling interpretation modules. While the specific components of these modules are likely to be expressed in many cell types, the relative level of second messenger molecules as well as of molecules further downstream could provide specificity to the response. Understanding this relatively less explored yet important layer of cell differentiation is likely to shed more light on how cells regulate a range of processes and respond to different signals.

We suggest that based on the differentiation state of a cell, these second messengers and molecules further downstream of them could be present in different proportions. In this way, the interpretation of GPCR signaling would vary in each cell type, leading to different outcomes. It would thus be interesting to determine those parameters for different responses to chemokine receptors and determine if one can modulate the consequence of chemokine signaling in a predicted way.

Materials and methods {#s4}
=====================

Zebrafish strains {#s4-1}
-----------------

Zebrafish (*Danio rerio*) of AB background were used as wild-type fish. Embryos from transgenic fish carrying *sox17:EGFP* ([@bib38]) were used to investigate the capability of different chemokine receptors to regulate endoderm positioning. *ccr7^stl7/stl7^* homozygous mutant embryos (see below) carrying *gsc:GFP* transgene and AB fish carrying *gsc:GFP* transgene were used to assess the competence of different chemokine receptors in regulating dorsoventral axis maintenance. The *odysseus* (*ody*; [@bib24]) fish line, homozygous for the mutation in *cxcr4b* gene, was used to assess the capability of different chemokine receptors to induce directed migration in PGCs, to demonstrate the ability of PGCs to undergo reverse migration upon exposure to high concentration of ligand and to test the effect of LPP overexpression on gastrulation.

Generation of *ccr7 stl7* mutant {#s4-2}
--------------------------------

The *ccr7* mutant was generated by TALEN system. The sequences of *ccr7* TALEN targets are 5'TCCAACATGACTGAACAC and 5'TCATACTCTGTTGTAG, designed by ZiFit (<http://zifit.partners.org/ZiFiT/>) ([@bib50]) and TALEN plasmids were constructed using REAL Assembly TALEN Kit (Addgene TALEN kit 1000000017) as described previously ([@bib50]; [@bib51]). The TALEN RNAs were synthesized using SP6 mMessageMachine Kit (Ambion) and injected into the one-cell stage eggs with 20--50 pg of each RNA. The mutagenic activity of the TALENs and mutant screen were assessed by restriction fragment length polymorphism (RFLP) analysis. Briefly, we first isolated the genomic DNAs from the TALEN RNAs injected embryos, amplified the TALEN target region of *ccr7* locus using the primer set (5'TCCAACATGACTGAACACCAAATG and 5'AGGTCAGGATGACCAGAAAGTTCC), and checked whether HphI recognition sequences are mutated in the TALEN target region. Fragment size were: 162, 37 bp for WT allele and 199, 162, 37 bp for *ccr7* heterozygous mutant allele. Sequence alignment of wild-type *ccr7* and mutated *ccr7* can be found in [Supplementary file 1](#supp1){ref-type="supplementary-material"}; *ccr7^stl7^* allele is 8 bp deletion in Exon three that is predicted to cause a frameshift and premature stop codon.

RNA expression constructs, morpholinos and injections {#s4-3}
-----------------------------------------------------

A list of all the constructs used in the study and amounts used for injection are provided in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. A list of all the primers and morpholinos used in the study is provided in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

To express proteins preferentially in germ cells, the corresponding ORF was cloned upstream of the *3'UTR* of *nanos3* gene ([@bib26]). To express proteins globally, the corresponding ORFs were cloned upstream of the *3'UTR* of the *Xenopus globin* gene.

To direct the expression of Cxcl12a to endoderm its mRNA was co-injected with mRNA encoding for the constitutively active form of the TARAM-A protein into one of the 16 blastomeres ([@bib44]).

Capped mRNA used for injection was synthesized using mMessageMachine kit from Ambion.

Detection of mRNA expression pattern {#s4-4}
------------------------------------

To determine relative position of PGCs expressing control, Cxcr4a or Cxcr4b mRNA with respect to expression pattern of *Cxcl12a* and *cxcl12b*, RNAscope *in situ* hybridization procedure was performed as previously described ([@bib19]).

For dorsoventral axis specification experiments, eggs were harvested immediately after they were laid and ramped in 1.5% agarose ramps. 2 nl of receptor and ligand or *control* RNA were injected into the newly forming cell. *Δβ-catenin* RNA was then injected into the cell as well. The same needle was used to inject *Δβ-catenin* in control and experimental embryos, to maintain identical volume of injection

Image acquisition {#s4-5}
-----------------

Still images of live zebrafish embryos were acquired using Zeiss Axioplan2 and a Zeis Axiolmager.Z1 microscopes controlled by the Visiview software, or on a Zeiss stereo microscope controlled by the Zeiss software. Still images of 5 hpf, 8 hpf and 10 hpf embryos were acquired at 10X magnification. Time-lapse movies showing reverse migration of PGCs were acquired at 10X magnification as well. For the time-lapse movies, an image was acquired every 2 min over a period of 180 min with exposure of 80 ms over 15 different focal planes. Still images showing internalization of receptors were acquired at 63X Magnification, using 488 nm and 561 nm laser sources.

Image analysis {#s4-6}
--------------

In the endoderm positioning experiment, the displacement of this germ layer was evaluated by measuring the vertical distance between the lowest positioned endodermal cell and forerunner cells, as illustrated in the [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.

In the dorsoventral axis specification experiment, background was subtracted in the FIJI software using the rolling ball algorithm with 130 size. Median filter with size two was applied following Autothreshold. Either Yen or Default autothreshold algorithm was used in the study to determine the pixels showing GFP expression above threshold.

In the reverse migration experiment, PGCs were tracked using the Imaris software. Movement of the endoderm tissue was averaged and subtracted, followed by analysis of PGCs movement with respect to the endoderm.

Statistical analysis {#s4-7}
--------------------

Kruskal-Wallis test was performed, correcting for multiple testing. Error bars represent S.E.M. ns = nonsignificant. \*p≤0.05. \*\*p≤0.01, \*\*\*p≤0.001, \*\*\*\*p≤0.0001.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Spatio-temporal regulation of concurrent developmental processes by generic signaling downstream of chemokine receptors\" for consideration by *eLife*. Your article has been favorably evaluated by K VijayRaghavan (Senior Editor) and three reviewers, one of whom, Holger Gerhardt (Reviewer \#1), is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Malhotra et al. use zebra fish germ cell migration and gastrulation as model processes to address the question to which extent the function of chemokine receptors is specific for a certain receptor ligand pair, for a certain physiological process and a certain cell type. By transplanting receptor ligand pairs between cells and context the authors find that receptor ligand systems are to a remarkable extent interchangeable and that it is the cell type that specifies the physiological response of the cell. They propose that, the decisive entity is the signal interpretation module, which determines what a cell will do upon receiving a GPCR stimulus.

All three reviewers find the results remarkable and the emerging concept important as it has the potential to change the angle how the field looks at chemokine receptor signalling. Furthermore, the focus on cellular context rather than specific functions of certain ligand receptor pairs also bears significant impact on strategies for therapeutic advances that exploit chemokine signalling as target. The following points should be addressed before publication:

Essential revisions:

1\) The referees feel that although the manuscript is overall well written and most essential background is presented and discussed, there are a few points that deserve adding to the text either as Introduction or Discussion points. Previous studies and reviews have already shown that signals are information-poor and that it is mostly the state of the cell not the specific ligand/receptor that determines signaling outcome. See for example Freeman and Gurdon ARCDB 2002. Similarly, the GPCR cytoplasmic domain swops should be added to the Introduction.

2\) It will be valuable for the reader if the authors would discuss the limitations and implications of their approach. Below are examples of points that the referees feel deserve discussion:

a\) The ideal experimental approach would be the replacement of endogenous ligands/receptors via knock-ins rather than the reported RNA injections. For example, PGC migration is only assayed by attraction to one side rather than true rescue.

b\) Does the over/mis-expression of ligands and receptors lead to ectopic phenotypes in an otherwise wild-type background (in addition to the reported rescue of mutants/morphants)? The model would suggest that cells should be misguided by ectopic inputs that compete for the same downstream effectors.

c\) It is surprising how well ubiquitous ligand/receptor expression rescues the mutant/morphant phenotypes. Isn\'t there a requirement for spatially and temporally localized signaling? And wouldn\'t this approach lead to autocrine signaling?

d\) How reliable was the rescue at different concentrations?

3\) Another point to be discussed/clarified, is the phenotype in the *ccr7* mutant. It seems to be much weaker than the previously published morphant. Is that correct? If so, it would seem worthwhile to mention/discuss.

4\) Finally, the omission of a third GPCR system (Apelin/Apela) that is also active in the early embryo deserves a comment. Would the model also hold true for this system? And does ectopic expression of the CXCR4 or CCR7 systems interfere with the Apelin/Apela system, as predicted by the model? The reviewers feel this should at least be discussed, if it cannot be addressed experimentally with reasonable efforts for a revision.

10.7554/eLife.33574.034

Author response

> Essential revisions:
>
> 1\) The referees feel that although the manuscript is overall well written and most essential background is presented and discussed, there are a few points that deserve adding to the text either as Introduction or Discussion points. Previous studies and reviews have already shown that signals are information-poor and that it is mostly the state of the cell not the specific ligand/receptor that determines signaling outcome. See for example Freeman and Gurdon ARCDB 2002. Similarly, the GPCR cytoplasmic domain swops should be added to the Introduction.

As requested, we added relevant references (see below). It should be noted however that those previous studies demonstrated that one receptor can control different processes in different cell types. While consistent with our suggestion, our findings go beyond this notion. We show that not only can the same receptor control different processes in different cells, but also that different receptors can control the same process.

\- The "information-poor" notion (and relevant references (Caulfield, 1993; Freeman and Gurdon, 2002; Queenan et al., 1999)), is now presented in the paragraph in the Discussion starting with "While the principle of generic signals and cell-specific \[...\]".

\- The domain swapping of GPCRs reported in (Xu et al., 2014) is now mentioned in the Introduction in the paragraph starting with "Several models have been suggested to explain this phenomenon \[...\]".

> 2\) It will be valuable for the reader if the authors would discuss the limitations and implications of their approach. Below are examples of points that the referees feel deserve discussion:
>
> a\) The ideal experimental approach would be the replacement of endogenous ligands/receptors via knock-ins rather than the reported RNA injections. For example, PGC migration is only assayed by attraction to one side rather than true rescue.

The aim of expressing the foreign receptors in the PGCs and the attraction towards ectopic locations was to demonstrate that the different receptors can in principle control the directional migration of PGCs.

We agree with the referee that exchanging receptors and ligand pairs by knock-ins and observing that the process proceeds normally would indeed be a very convincing demonstration of the principle we suggest. One should remember though that experiments of this kind also have limitations and might not always be successful. Such an experimental setup would not allow calibration of the receptor and ligand level at all, decoy receptors for specific ligands would not function, differences among ligand diffusion rates, ligand-receptor affinity, signaling level etc. could make a perfect phenotypic rescue impossible, despite the signal being qualitatively equivalent.

> b\) Does the over/mis-expression of ligands and receptors lead to ectopic phenotypes in an otherwise wild-type background (in addition to the reported rescue of mutants/morphants)? The model would suggest that cells should be misguided by ectopic inputs that compete for the same downstream effectors.

This point is indeed valid and observing misguidance of germ cells (for example) under such conditions would lend further support to the model we propose.

Cxcr4a is not expressed in wild-type PGCs and is not involved in guiding their migration. In the new experiment we present in the revised manuscript, germ cells were engineered to express Cxcr4a receptor and their positioning was examined (Figure 5---figure supplement 1). According to our model, under such experimental conditions the migration of the cells would be influenced by Cxcl12b (the ligand of Cxcr4a), whose expression pattern differs from that of the endogenous Cxcr4b ligand Cxcl12a. During early development the expression of Cxcl12b is rather ubiquitous in contrast with Cxcl12a (the endogenous ligand of Cxcr4b) that is preferentially expressed within specific domains (Doitsidou et al., 2002). Indeed, despite the fact that Cxcl12a is highly expressed at these stages of development, expressing Cxcr4a in the germ cells interfered with their clustering. This point is now shown in Figure 5---figure supplement 1 and is presented in the paragraph starting with "The finding that different types of chemokine receptors depend on the same signaling cascade \[...\]".

> c\) It is surprising how well ubiquitous ligand/receptor expression rescues the mutant/morphant phenotypes. Isn\'t there a requirement for spatially and temporally localized signaling? And wouldn\'t this approach lead to autocrine signaling?

Spatially restricted chemokine expression is indeed important for certain processes, directed cell migration for example. Accordingly, rescuing the chemokine directed migration of cells towards a specific region would not be possible by ubiquitous expression of the receptor and the ligand. For this reason we examine the ability of receptors to guide cell migration using the setup presented in Figure 3. Here, the ligand is expressed at a discrete part of the embryo and the cells are guided towards it by signals provided by a "foreign" receptor. This point is now described more clearly in the text in the paragraph starting with "To further test the capability of receptors to direct cell migration \[...\]"

The ubiquitous ligand/receptor expression experiments were conducted in contexts where the endogenous ligands are not spatially restricted at the time of action for the processes we examined. In those cases the spatial restriction of the ligand is not required as the signal acts on many cells that express the relevant receptor in enhancing cell adhesion (in the case of Cxcr4a), or inhibiting *β*-catenin function (in the case of dorso-ventral patterning mediated by Ccl19). Therefore, in cases where the required signal does not provide spatial information, the activation of the receptor by paracrine or autocrine mechanism can both rescue the loss of function phenotype. We now include those considerations in the text in the paragraph starting with "To further investigate if the signals the two receptors \[...\]".

> d\) How reliable was the rescue at different concentrations?

The fact the processes we examine are not extremely sensitive to the overall levels of the receptors or ligands can first be appreciated by the fact that the corresponding mutations (e.g. in *cxcl12a, cxcl12b, cxcr4a* and *cxcr4b* genes) are recessive. In addition, as exemplified by germ cells migrating towards a chemokine source, the same response can be observed over a large range of ligand concentrations as the PGCs get closer to the cells expressing the ligand (e.g. in the wild-type situation). Consistently, altering the level of the Cxcr4b and Cxcl12a by alleviating the miRNA regulation results in an extremely weak PGC migration phenotype (1 out of 30 cells located ectopically (Staton et al., 2011), or no phenotype at all (Goudarzi et al., 2013).

In this work we typically tried 1-3 different concentrations of ligand/receptors and used the one that provided the most consistent results.

To demonstrate the robustness of the rescue, we expressed different concentrations of Ccr9 and observed effective response to its ligand in embryos injected with a range of RNA amounts. We expressed different amounts of Ccr9 in germ cells and observed effective migration of the cells towards parts of the embryo expressing the cognate ligand. This experiment is now presented in Figure 3---figure supplement 1. As can be observed in this figure, at very low concentrations of the receptor the rescue is not as reliable. This point is mentioned in the first paragraph of the Discussion (see - "Consistently, the cell-specific biological response \[...\]"). Together with the experience from setting up the different experiments, we conclude that within a broad range, the level of the expressed receptor and ligand result in a similar biological effect. This could result from robustness of the interpretation module to changes in signal level, or from mechanisms controlling the signal level (e.g.(Minina et al., 2007)).

> 3\) Another point to be discussed/clarified, is the phenotype in the ccr7 mutant. It seems to be much weaker than the previously published morphant. Is that correct? If so, it would seem worthwhile to mention/discuss.

Whereas *ccr7* morpholino causes strong dorsalization manifest in elongated embryo shapes at late gastrulation (Wu et al., 2012), neither zygotic *ccr7* nor maternal zygotic (MZ) *ccr7* mutants described here displayed similar morphologic defects and grew into fertile adults. qRT-analyses revealed downregulation of *ccr7* transcripts in MZ*ccr7* mutants consistent with a strong loss of function. As described in the results, MZ*ccr7* exhibit increased sensitivity to β-catenin induced dorsalization (Figure 4---figure supplement 1), consistent with Ccr7 acting as a negative but unessential regulator of β-catenin. To explore the inconsistency between the *ccr7* morphant and mutant phenotypes, we considered off-target effect of the *ccr7*-MO1 and genetic compensation as possible mechanisms (Rossi et al., 2015). Inconsistent with a genetic compensation operating in *ccr7* mutants, upon injection of *ccr7*-MO1, MZ*ccr7* mutants showed strong dorsalization phenotype comparable to that observed in wild-type embryos injected with the same morpholino dose. This result suggests that the morphant phenotype may be due to off-target effects on genes that encode negative regulators of β-catenin and are thus functionally redundant with *ccr7*. This would explain that MZ*ccr7* mutants appear phenotypically normal, but they are sensitive to the level of β-catenin. Intriguingly, at least 12 chemokine GPCRs are expressed at the early cleavage stages of zebrafish embryo (Jimann Shin and LSK, unpublished observations), and findings in this manuscript indicate that Ccr7's effect on β-catenin and the extent of dorsalization can be directed by other chemokine receptors from different families. In addition, *ccr7*-MO1 modulated Ca^2+^ signaling (Wu et al., 2012), making genes encoding other GPCRs likely targets of this morpholino. However, *ccr7*-MO1 targeting other negative regulators of *β* -catenin cannot be excluded at the moment. We are systematically mutating all chemokine GPCRs in zebrafish to distinguish between these possibilities (Jimann Shin and LSK, unpublished).

We present this information in the paragraph starting with "Since the biological contexts studied above \[...\]"

> 4\) Finally, the omission of a third GPCR system (Apelin/Apela) that is also active in the early embryo deserves a comment. Would the model also hold true for this system? And does ectopic expression of the CXCR4 or CCR7 systems interfere with the Apelin/Apela system, as predicted by the model? The reviewers feel this should at least be discussed, if it cannot be addressed experimentally with reasonable efforts for a revision.

The main finding of the manuscript is that GPCRs of the chemokine family elicit an equivalent signaling cascade that is differentially interpreted by different cell types. The extent to which this finding applies to other GPCR families is an interesting question, which we touched upon by examining the LPA/S1P receptor. In these experiments we could show that the "universal signal" hypothesis can in principle be extended beyond the chemokine family. In response to this question we attempted to rescue the endoderm ingression phenotype resulting from the mutation in the *apela* locus. In these experiments we could not reverse the *apela* phenotype suggesting a qualitative difference between chemokine receptor signaling and the signal produced by the Apela receptor, or signifying a requirement for tight control over the dynamics of receptor activation. We now mention this point in the paragraph starting with "While based on our results chemokine receptors elicit qualitatively similar signals \[...\]" and made sure that it is clear from the text (as stated in the title of the paper), that the main statement relates to the chemokine receptor family of GPCRs.
